We pulled back to being a service organization, maintained our customer base, kept them functioning, and now that we ve re-launched, we re actually growing into all three markets. One of the things that was brought out to the Medicare Advisory Committee for HCFA, just two weeks ago, was that because it goes down to the molecular level, PET is useful for all cancer applications. In addition, you re going to see more and more where PET is going to be used for drug research as we get more and more into gene therapy. Heart disease is the number one killer of American men and women. Some 650,000 Americans will die this year in the United States alone of heart disease.
Cancer is the number two killer of American men and women.
There will be 1.2 million new cancer cases this year and 525,000 Americans will die of cancer. Stroke is the number three killer of American men and women with 160,000 Americans dying this year. PET is the perfect combination of better medicine, better patient care and reduced medical costs. We ve done more patients than any other system around. We have systems at Cleveland Clinic, Beth Israel New York, and Crawford Long of the Emory Health System.